Top 10 Private Equity Investors in the Medical Industry in the World in 2021 by Deal Value

Hellman & Friedman LLC, The Carlyle Group Inc., CVC Capital Partners SICAV-FIS SA, Bain Capital LP, and EQT AB are among the top 5 private equity investors in the medical industry in 2021 by deal value. In terms of the geographic split, 7 out of the world’s top 10 private equity investors in the medical industry are headquartered in North America, whereas the remaining 3 are based in Europe. They employed a total of 4,671 people in 2021. The Hellman & Friedman-Veritas Capital deal was one of the major deals in the medical sector in 2021. Evercore and Goldman Sachs & Co. LLC. served as lead financial advisors, while Milbank LLP served as a legal advisor to athenahealth. Affiliates of Hellman & Friedman and Bain Capital have completed their acquisition of athenahealth, Inc, a provider of cloud-based enterprise software solutions for medical groups and health systems, from Veritas Capital and Evergreen Coast Capital, for $17 billion. The deal was completed in Q1 2022. The EQT-Parexel International deal was another major deal in the medical sector in 2021. Evercore served as the financial advisor to Parexel. EQT Partners, a private equity firm, and Goldman Sachs Group, an investment banking, securities, and investment management firm, have acquired Parexel International Corp, a contract research company, from Pamplona Capital Management LP, an alternative investment platform, for a purchase consideration of $8.5 billion. The deal was completed in Q4 2021. The TPG Sixth Street-Caris Life Sciences deal was another major deal in the medical sector in 2021. Shearman & Sterling LLP served as legal advisor to Caris Life Sciences Inc. Caris Life Sciences, an innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. The deal was completed in Q2 2021.